B7H3

Clinical trials for B7H3 explained in plain language.

Never miss a new study

Get alerted when new B7H3 trials appear

Sign up with your email to follow new studies for B7H3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New radioactive drug targets tough prostate cancer in early trial

Disease control Recruiting now

This early-phase study tests a new radioactive drug called [225Ac]Ac-AKY-2519 in people with a hard-to-treat type of advanced prostate cancer (metastatic castration-resistant prostate cancer). The drug targets a protein (B7-H3) on cancer cells to deliver radiation directly to tum…

Matched conditions: B7H3

Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control

Last updated May 13, 2026 16:02 UTC

B7H3

Get alerted when new B7H3 trials appear

New radioactive drug targets tough prostate cancer in early trial